Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 9, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 12, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-458304
Filed / recorded
Nov 12, 2026, 9:05 PM UTC
Added to OQRO
Nov 12, 2026, 9:07 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Syndax Pharmaceuticals Inc
Issuer CIK
1395937
Ticker
SNDX
Reporting person
Aaron Ondrey
Relationship
Officer
Officer title
Chief Financial Officer
Security
Stock Option (Right to buy)
Table
Derivative (Table II)
Transaction date
Nov 9, 2026
Transaction code
A
Shares / units
270,000
Price per share
$9.55
Acquired / disposed
Acquired (A)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
Twenty-five percent (25%) of the total number of shares will vest on the one (1) year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the shares of Common Stock subject to the Option shall vest monthly thereafter during the recipient's continued service as an employee, consultant, director or officer of the Company over the following thirty-six (36) months, until all of the shares subject to the Option are fully vested.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.